Pilot Study Evaluating Pharmacokinetic Parameters of Capecitabine Dosing in Patients With Advanced Cancer and Elevated Body Mass Index

Trial Profile

Pilot Study Evaluating Pharmacokinetic Parameters of Capecitabine Dosing in Patients With Advanced Cancer and Elevated Body Mass Index

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 03 Feb 2017

At a glance

  • Drugs Capecitabine (Primary)
  • Indications Obesity; Solid tumours
  • Focus Pharmacokinetics
  • Most Recent Events

    • 30 Jan 2017 Planned End Date changed from 1 Jun 2017 to 1 Dec 2017.
    • 30 Jan 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Dec 2017.
    • 13 Dec 2016 Planned End Date changed from 1 Dec 2016 to 1 Jun 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top